Corrigendum: Blocking C-Met–mediated PARP1 Phosphorylation Enhances Anti-Tumor Effects of PARP Inhibitors

Nature Medicine - United Kingdom
doi 10.1038/nm1016-1192c
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

284 Differential Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors

European Journal of Cancer
Cancer ResearchOncology
2012English

C-Met Inhibitors

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2013English

P1.03-20 the Novel SFN Inhibitors Aprepitant and Ticagrelor Exert Anti-Tumor Effects Through Blocking of Oncoprotein Ubiquitination

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

HMGA2 as a Functional Antagonist of PARP1 Inhibitors in Tumor Cells

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

Bazedoxifene Enhances the Anti-Tumor Effects of Cisplatin and Radiation Treatment by Blocking IL-6 Signaling in Head and Neck Cancer

Oncotarget
Oncology
2016English

Bromelain Enhances the Anti-Tumor Effects of Cisplatin on 4T1 Breast Tumor Model in Vivo

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2019English

Design and Synthesis of 3,3′-Biscoumarin-Based C-Met Inhibitors

Organic and Biomolecular Chemistry
Organic ChemistryTheoretical ChemistryBiochemistryPhysical
2014English

GD3 Synthase Expression Enhances Proliferation and Tumor Growth of MDA-MB-231 Breast Cancer Cells Through C-Met Activation

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

PARP Inhibitors in Ovarian Cancer

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy